Professur für Translationale Frauenheilkunde und Geburtshilfe

Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study (2016) Gaß P, Fasching P, Fehm T, De Waal J, Rezai M, Baier B, Baake G, et al. Journal article Genetic predisposition to ductal carcinoma in situ of the breast (2016) Petridis C, Brook MN, Shah V, Kohut K, Gorman P, Caneppele M, Levi D, et al. Journal article Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry (2016) Zhao Z, Wen W, Michailidou K, Bolla MK, Wang Q, Zhang B, Long J, et al. Journal article Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study (2016) Dixon SC, Nagle CM, Thrift AP, Pharoah PDP, Pearce CL, Zheng W, Painter JN, et al. Journal article Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial (2016) Jueckstock J, Rack B, Friedl TWP, Scholz C, Steidl J, Trapp E, Tesch H, et al. Journal article CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients (2016) Rack B, Jueckstock J, Trapp E, Weissenbacher T, Alunni-Fabbroni M, Schramm A, Widschwendter P, et al. Journal article Association of CA27.29 and Circulating Tumor Cells Before and at Different Times After Adjuvant Chemotherapy in Patients with Early-stage Breast Cancer - The SUCCESS Trial (2016) Hepp P, Andergassen U, Jaezger B, Trapp E, Alunni-Fabbroni M, Friedl TWP, Hecker N, et al. Journal article Documentation Time and Effort and Associated Resources for Patients with Primary Breast Cancer from Diagnosis to End of Follow-Up - Results of a Multicentre Validation (2016) Beckmann M, Sell C, Aydogdu M, Brucker SY, Fehm T, Janni W, Kreienberg R, et al. Journal article Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined with Gemcitabine as an Adjuvant Treatment for High-Risk Early Breast Cancer: the SUCCESS-A Trial (2016) Schroeder L, Rack B, Sommer H, Koch JG, Weissenbacher T, Janni W, Schneeweiss A, et al. Journal article The International Endometriosis Evaluation Program (IEEP Study) - A Systematic Study for Physicians, Researchers and Patients (2016) Burghaus S, Fehm T, Fasching P, Blum S, Renner S, Baier F, Brodkorb T, et al. Journal article